Skip to main content

Table 1 Demographics

From: Lipid profiles in schizophrenia associated with clinical traits: a five year follow-up study

 

Patients T1

Healthy controls T1

Patients T2

Healthy controls T2

n = 55

n = 20

n = 55

n = 51¤

Age

26.5 ± 6.1

31.1 ± 5.3

31.3 ± 5.7

33.0 ± 6.1

Sex (% male)

69.1

55.0

69.1

54.9

Smokers (%)

31 (56.4)

7 (35.0)

29 (52.7)

9 (17.6)

Primary school (%) a

14 (25.5)

3 (15.0)

9 (17.0)

1 (2.0)

Secondary school (%)

30 (54.5)

8 (40.0)

30 (56.6)

8 (16.0)

University / college (%)

11 (20.0)

9 (45.0)

14 (26.4)

41 (82.0)

PANSS total

81 (71,93)

 

82 (57,101)

 

PANSS negative

22 (16,27)

 

25 (18,31)

 

PANSS positive

17 (13,21)

 

16 (11,19)

 

GAF-S

35 (30,40)

 

45 (37,58)

 

GAF-F

37 (31,40)

 

47 (38,58)

 
  1. PANSS positive and negative symptoms scale
  2. PANSS total positive and negative symptoms scale
  3. PANSS positive positive component: items P1 + P3 + P5 + P6 + G9
  4. PANSS negative negative component: items N1 + N2 + N3 + N4 + N6 + G7 + G8 + G16
  5. GAF global assessment of functioning, S symptoms, F functioning
  6. Age mean ± standard deviation
  7. PANSS, GAF: median (25,75 percentiles)
  8. a data missing from patient T2 n = 2, control T2 = 1
  9. ¤ 16 healthy controls from T1, 35 additional healthy controls included at T2